Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On August 3, 2015

BOULDER, Colo., July 27, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the fourth quarter and full year of fiscal 2015 and hold a conference call to discuss those results on Monday, August 3, 2015.  Ron Squarer, Chief Executive Officer will lead the call.

 Array BioPharma.



Monday, August 3, 2015


9:00 a.m. Eastern Time


(844) 464-3927


(765) 507-2598

Pass Code:    


Webcast, including Replay and Conference Call Slides: 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to


Tricia Haugeto                         

Array BioPharma Inc.

(303) 386-1193

Logo -


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.